A carregar...
Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
Atazanavir/cobicistat (ATV/c) and darunavir/cobicistat (DRV/c) are newly approved once daily fixed-dose protease inhibitor combinations for the treatment of HIV-1 infection. Studies in healthy volunteers have established bioequivalence between cobicistat and ritonavir as pharmacoenhancers of both at...
Na minha lista:
| Publicado no: | HIV AIDS (Auckl) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4790521/ https://ncbi.nlm.nih.gov/pubmed/27022304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S99063 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|